Amedeo Smart

Free Medical Literature Service

 

Amedeo

Lung Cancer
  Free Subscription

Articles published in
J Thorac Cardiovasc Surg
    October 2025
  1. ALTORKI N, Damman B, Wang X, Liberman M, et al
    The extent of lymph node dissection is not associated with disease-free survival following lobar or sublobar resection: Results from Cancer and Leukemia Group B 140503 (Alliance).
    J Thorac Cardiovasc Surg. 2025;170:933-942.
    >> Share

  2. GOMES C, Cowan B, Xiao M, Morris P, et al
    Diagnostic effectiveness and safety of robotic-assisted bronchoscopy for subsolid pulmonary nodules: A multicenter prospective observational study.
    J Thorac Cardiovasc Surg. 2025;170:945-954.
    >> Share

  3. BUI J, Kalata S, Reddy RM, Clark M, et al
    An evaluation of lymph node harvest in sublobar resections in a statewide quality collaborative.
    J Thorac Cardiovasc Surg. 2025;170:915-923.
    >> Share

    September 2025
  4. PAN G, Yang G, Wang W, Liu H, et al
    Resection for stage IV non-small cell lung cancer: Beyond the extent of resection.
    J Thorac Cardiovasc Surg. 2025 Sep 4:S0022-5223(25)00658.
    >> Share

    August 2025
  5. CASO R, Zhou N, Skovgard M, Toumbacaris N, et al
    Lobectomy Improves Disease-Free Survival Over Sublobar Resection for High-Risk Stage IA Non-Small Cell Lung Cancer.
    J Thorac Cardiovasc Surg. 2025 Aug 29:S0022-5223(25)00678.
    >> Share

  6. WEI M, Guo S
    Reconsidering bias and interpretation in neoadjuvant stereotactic body radiotherapy combined with immunotherapy versus standard chemoimmunotherapy for non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2025 Aug 27:S0022-5223(25)00652.
    >> Share

  7. CHRISTIE I, Luketich JD, Schuchert MJ, Slingerland A, et al
    Image-guided Radiofrequency Ablation for Treatment of Stage I Non-Small Cell Lung Cancer in 111 High-risk Patients: Analysis of Prognostic Variables.
    J Thorac Cardiovasc Surg. 2025 Aug 20:S0022-5223(25)00669.
    >> Share

  8. PARIKH MJ, Russo MG, Tompkins AK, Erkmen CP, et al
    Reply: Multilevel bridge to lung cancer screening adherence.
    J Thorac Cardiovasc Surg. 2025 Aug 7:S0022-5223(25)00559.
    >> Share

    July 2025
  9. MARTIN LW
    Towards a Chemotherapy-Free Future: Adjuvant Alectinib in Early Stage Non-Small Cell Lung Cancer.
    J Thorac Cardiovasc Surg. 2025 Jul 29:S0022-5223(25)00580.
    >> Share

  10. KNEUERTZ PJ, Villamizar N, Altorki NK, Phillips JD, et al
    Minimally Invasive Resection of Non-small Cell Lung Cancer after Chemoimmunotherapy - A Multicenter Study in Academic Hospitals.
    J Thorac Cardiovasc Surg. 2025 Jul 25:S0022-5223(25)00637.
    >> Share

  11. JONES D, Nasar A, Villena-Vargas J, Harrison S, et al
    Neoadjuvant Non-Ablative SBRT Plus Immunotherapy Yields Similar Pathologic Response as Chemo-Immunotherapy in Non-Small Cell Lung Cancer.
    J Thorac Cardiovasc Surg. 2025 Jul 18:S0022-5223(25)00571.
    >> Share

  12. SI H, Feng Y, Dong Y, Yu J, et al
    Validation and refinement of the ninth edition ypN descriptor in patients with non-small cell lung cancer receiving neoadjuvant therapy.
    J Thorac Cardiovasc Surg. 2025 Jul 17:S0022-5223(25)00572.
    >> Share

  13. KHER S
    No cancer left behind: Systematic follow-up systems are essential to improve adherence to lung cancer screening.
    J Thorac Cardiovasc Surg. 2025 Jul 5:S0022-5223(25)00529.
    >> Share

  14. INAN GA, Aksakal AK, Ayrak FB, Ergiden C, et al
    Interpreting survival comparisons in stage III non-small cell lung cancer: Performance bias and the need for subgroup-specific analysis.
    J Thorac Cardiovasc Surg. 2025 Jul 2:S0022-5223(25)00473.
    >> Share

  15. ZERVOS M, Park BJ, Marshall MB, Wee JO, et al
    Robotic-assisted single-port system for pulmonary lobectomy: A prospective feasibility study.
    J Thorac Cardiovasc Surg. 2025;170:54-60.
    >> Share

    April 2025
  16. BASKIN AS, Funk EC, Francescatti AB, Sinco BR, et al
    Early Compliance with Lung Cancer Lymph Node Standard 5.8: An Analysis of 2022 and 2023 Commission on Cancer Site Reviews.
    J Thorac Cardiovasc Surg. 2025 Apr 29:S0022-5223(25)00340.
    >> Share

  17. EISENBERG MA, Werner R, Ries S, Hofstetter WL, et al
    Extent of Resection in Surgically Resected Stage IV Non-Small-Cell Lung Cancer: Results from Two Tertiary Referral Centers.
    J Thorac Cardiovasc Surg. 2025 Apr 23:S0022-5223(25)00327.
    >> Share

  18. LI H, Pezeshkian F, Xie Y, Mazzola E, et al
    Lung Cancer Recurrence after Neoadjuvant Immunotherapy.
    J Thorac Cardiovasc Surg. 2025 Apr 20:S0022-5223(25)00328.
    >> Share

  19. WILLIAMS JE, Jacobs RC, Savitch SL, Hollenbeck ME, et al
    Provider and Procedural Factors Associated with Guideline-Concordant Lymph Node Sampling in Lung Cancer Resection.
    J Thorac Cardiovasc Surg. 2025 Apr 17:S0022-5223(25)00304.
    >> Share

  20. ANTONOFF MB, Gay CM
    Timing of local consolidative pulmonary resection for oncogene-driven stage IV lung cancer.
    J Thorac Cardiovasc Surg. 2025 Apr 3:S0022-5223(25)00281.
    >> Share

  21. MITRA S, Jang HJ, Kuncheria A, Kang SW, et al
    Soluble mesothelin-related peptide as a prognosticator in pleural mesothelioma patients receiving checkpoint immunotherapy.
    J Thorac Cardiovasc Surg. 2025;169:1082-1095.
    >> Share

  22. HUANG J, Tan KS, Altorki N, Antonoff M, et al
    Initial patient characteristics of Thoracic Surgical Oncology Group 102: A multicenter prospective registry of active surveillance in patients with multiple ground-glass opacities.
    J Thorac Cardiovasc Surg. 2025;169:1100-1107.
    >> Share

  23. CAO H, Zhu W, Tang H, Deng C, et al
    Dissecting the clinicopathologic, genomic, and prognostic significance of anaplastic lymphoma kinase rearrangement in resected lung adenocarcinoma.
    J Thorac Cardiovasc Surg. 2025;169:1143-1152.
    >> Share

  24. STANIFER BP, Harris S, Nguyen SN, Vinogradsky AV, et al
    Surgical management of pleural complications in lymphangioleiomyomatosis.
    J Thorac Cardiovasc Surg. 2025;169:1133-1141.
    >> Share

    March 2025
  25. CURRY J, Pompili C
    Moving toward better outcomes: Time to be active before lung cancer surgery.
    J Thorac Cardiovasc Surg. 2025 Mar 11:S0022-5223(25)00123.
    >> Share


  26. Commentator Discussion: Time to surgery in early-stage non-small cell lung cancer (NSCLC): Defining the optimal diagnosis-to-resection interval to reduce mortality.
    J Thorac Cardiovasc Surg. 2025 Mar 6:S0022-5223(25)00104.
    >> Share

  27. CHO AR, Najafi T, Ramanakumar AV, Ferri L, et al
    The Effect of Multimodal Prehabilitation on Postoperative Outcomes in Lung Cancer Surgery.
    J Thorac Cardiovasc Surg. 2025 Mar 3:S0022-5223(25)00173.
    >> Share

    February 2025
  28. DENG H, Yu Z, Pan Y, Huang Y, et al
    SEGMENTECTOMY/WEDGE resection following neoadjuvant/induction immunochemotherapy in non-small cell lung cancer: Is it justified?
    J Thorac Cardiovasc Surg. 2025 Feb 7:S0022-5223(25)00008.
    >> Share

  29. FICK CN, Dunne EG, Toumbacaris N, Tan KS, et al
    Late recurrence of completely resected stage I to IIIA lung adenocarcinoma.
    J Thorac Cardiovasc Surg. 2025;169:445-453.
    >> Share

  30. FICK CN, Dunne EG, Vanstraelen S, Toumbacaris N, et al
    High-risk features associated with recurrence in stage I lung adenocarcinoma.
    J Thorac Cardiovasc Surg. 2025;169:436-444.
    >> Share

  31. PEZESHKIAN F, Leo R, McAllister MA, Singh A, et al
    Predictors of prolonged hospital stay after segmentectomy.
    J Thorac Cardiovasc Surg. 2025;169:420-426.
    >> Share

    January 2025
  32. HUANG X, Zhu L, Hu J
    Surgery for lung cancer: Time waits for no one.
    J Thorac Cardiovasc Surg. 2025 Jan 31:S0022-5223(25)00005.
    >> Share

  33. XU MM, Cerullo M
    Commentary: Missing 100% of the cancers you don't look for: pitfalls and performance of lung cancer screening efforts in a real-world setting.
    J Thorac Cardiovasc Surg. 2025 Jan 8:S0022-5223(25)00003.
    >> Share

  34. THERRIAULT CS, Kim AW
    Commentary: The Ticking Lung Cancer Clock.
    J Thorac Cardiovasc Surg. 2025 Jan 8:S0022-5223(25)00004.
    >> Share

  35. BOTT MJ, Toumbacaris N, Tan KS, Husta BC, et al
    Characterizing a learning curve for robotic-assisted bronchoscopy: Analysis of skills acquisition in a high-volume academic center.
    J Thorac Cardiovasc Surg. 2025;169:269-278.
    >> Share

    December 2024
  36. FUKUI M, Suzuki K
    Reply: Prognostic significance of preoperative exercise tolerance in patients with early-stage lung cancer.
    J Thorac Cardiovasc Surg. 2024 Dec 27:S0022-5223(24)01133.
    >> Share

  37. KOYLU B, Guven DC
    Controversial influence of adjuvant immunotherapy in survival outcomes for patients with non-small cell lung cancer with major/complete pathologic response.
    J Thorac Cardiovasc Surg. 2024 Dec 26:S0022-5223(24)01186.
    >> Share

  38. DE PERROT M
    Reply: The pulmonary sulcus phenomenon in lung cancer invading the chest wall.
    J Thorac Cardiovasc Surg. 2024 Dec 23:S0022-5223(24)01095.
    >> Share

  39. ALTORKI N, Wang X, Damman B, Mentlick J, et al
    Corrigendum to: Lobectomy, segmentectomy, or wedge resection for peripheral clinical T1aN0 non-small cell lung cancer: A post hoc analysis of CALGB 140503 (Alliance)" [The Journal of Thoracic and Cardiovascular Surgery Volume 167, Issue 1, January 202
    J Thorac Cardiovasc Surg. 2024 Dec 20:S0022-5223(24)01142.
    >> Share

  40. PARIKH MJ, Chai LF, Russo MG, Tompkins AK, et al
    Dismal Adherence to Lung Cancer Screening in a Diverse Urban Population.
    J Thorac Cardiovasc Surg. 2024 Dec 13:S0022-5223(24)01136.
    >> Share

  41. ZOLFAGHARI EJ, Ayoade O, Antonoff MB
    Barriers to fitness: Disparities in preoperative exercise access for patients with lung cancer.
    J Thorac Cardiovasc Surg. 2024 Dec 13:S0022-5223(24)01096.
    >> Share

  42. TUPPER HI, Sarovar V, Banks KC, Schmittdiel JA, et al
    Time to Surgery in Early-Stage Non-Small Cell Lung Cancer (NSCLC): Defining the Optimal Diagnosis-to-Resection Interval to Reduce Mortality.
    J Thorac Cardiovasc Surg. 2024 Dec 12:S0022-5223(24)01125.
    >> Share

  43. ZHU W, Han H, Ma Z, Cao H, et al
    Prognostic value of KRAS G12V mutation in lung adenocarcinoma stratified by stages and radiological features.
    J Thorac Cardiovasc Surg. 2024;168:1525-1537.
    >> Share

    November 2024
  44. ZHAO ZR, Yan WP, Yu XY, Zhang JB, et al
    Adjuvant Immunotherapy Does Not Improve Survival in Non-small Cell Lung Cancer with Major/Complete Pathological Response after Induction Immunotherapy.
    J Thorac Cardiovasc Surg. 2024 Nov 29:S0022-5223(24)01109.
    >> Share

  45. FERRARIS VA
    Commentary: On 'Gender, Race, and Ethnicity in Lung Cancer Clinical Trial Participation'.
    J Thorac Cardiovasc Surg. 2024 Nov 10:S0022-5223(24)01029.
    >> Share

  46. UDELSMAN BV, Bedrosian CK, Kawaguchi ES, Ding L, et al
    Living on the Edge: Role of Adjuvant Therapy After Resection of Primary Lung Cancer Within 2 Millimeters of a T-Stage Cutoff.
    J Thorac Cardiovasc Surg. 2024 Nov 7:S0022-5223(24)01021.
    >> Share


  47. Discussion to: Early real-world experience monitoring circulating tumor DNA in resected early-stage non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2024;168:1360-1361.
    >> Share


  48. Discussion to: Should sampling of 3 N2 stations be a quality metric for curative resection of stage I lung cancer?
    J Thorac Cardiovasc Surg. 2024;168:1346-1348.
    >> Share

  49. WANG S, Meng F, Chen P, Lv Y, et al
    Cell-free DNA assay for malignancy classification of high-risk lung nodules.
    J Thorac Cardiovasc Surg. 2024;168:e140-e175.
    >> Share

    October 2024
  50. GALVAING G, Drevet G, Tricard J, Gregoire J, et al
    Lung cancer invading the chest wall: The role of site of chest wall invasion.
    J Thorac Cardiovasc Surg. 2024 Oct 17:S0022-5223(24)00826.
    >> Share

  51. RABINOVICH EP, Martin LW
    Getting Patients to Adjuvant Therapy after Lung Cancer Resection: ERAS Protocols and Return to Intended Oncologic Therapy.
    J Thorac Cardiovasc Surg. 2024 Oct 10:S0022-5223(24)00916.
    >> Share

  52. HUTCHINGS H, Boyajian H, Okereke I
    Reply: Achieving environmental justice will reduce lung cancer health disparities.
    J Thorac Cardiovasc Surg. 2024 Oct 9:S0022-5223(24)00766.
    >> Share

  53. YUAN W, Huang R, Yang Z
    Will salvage surgery lead to a paradigm shift in the treatment of stage IV lung cancer?
    J Thorac Cardiovasc Surg. 2024 Oct 4:S0022-5223(24)00808.
    >> Share

  54. LEE JM
    Neoadjuvant, perioperative, or adjuvant immunotherapy in resectable non-small cell lung cancer: How do I choose? Importance of immune biomarkers and molecular testing.
    J Thorac Cardiovasc Surg. 2024;168:1281-1288.
    >> Share

  55. YANG Z, Wang S, Yang H, Jiang Y, et al
    Treatment patterns and clinical outcomes of patients with resectable non-small cell lung cancer receiving neoadjuvant immunochemotherapy: A large-scale, multicenter, real-world study (NeoR-World).
    J Thorac Cardiovasc Surg. 2024;168:1245-1258.
    >> Share

    September 2024
  56. KANUPARTHY M, Kanuparthy S, Harris DD, Broadwin M, et al
    Gender, Race, and Ethnicity in Lung Cancer Clinical Trial Participation: Analysis of 253,845 Patients From 2002 - 2021.
    J Thorac Cardiovasc Surg. 2024 Sep 28:S0022-5223(24)00893.
    >> Share

  57. FERRARI-LIGHT D, Merritt RE, D'Souza D, Ferguson MK, et al
    Evaluating ChatGPT as a Patient Resource for Frequently Asked Questions about Lung Cancer Surgery - A Pilot Study.
    J Thorac Cardiovasc Surg. 2024 Sep 24:S0022-5223(24)00837.
    >> Share

  58. BRUNELLI A, Antonoff MB, Petersen RH, Stiles BM, et al
    Surgeon preferences for self-treatment in locally advanced non-small cell lung cancer: Would we practice what we preach?
    J Thorac Cardiovasc Surg. 2024 Sep 19:S0022-5223(24)00526.
    >> Share

  59. ADACHI H, Ito H, Nagashima T, Isaka T, et al
    Mediastinal lymph node dissection in segmentectomy for peripheral c-stage IA (
    J Thorac Cardiovasc Surg. 2024 Sep 9:S0022-5223(24)00786.
    >> Share

  60. CHEN H, Kim AW, Hsin M, Shrager JB, et al
    The 2023 American Association for Thoracic Surgery (AATS) Expert Consensus Document: Management of subsolid lung nodules.
    J Thorac Cardiovasc Surg. 2024;168:631-647.
    >> Share


  61. Discussion to: Oncological characteristics of EGFR-mutated clinical stage IA lung adenocarcinoma with radiologically pure-solid appearance.
    J Thorac Cardiovasc Surg. 2024;168:697-698.
    >> Share


  62. Discussion to: Digital spatial profiling to predict recurrence in grade 3 stage I lung adenocarcinoma.
    J Thorac Cardiovasc Surg. 2024;168:658-659.
    >> Share

  63. HATTORI A, Matsunaga T, Fukui M, Tomita H, et al
    Oncological characteristics of epidermal growth factor receptor-mutated clinical stage IA lung adenocarcinoma with radiologically pure-solid appearance.
    J Thorac Cardiovasc Surg. 2024;168:685-696.
    >> Share

  64. CHANG SH, Mezzano-Robinson V, Zhou H, Moreira A, et al
    Digital spatial profiling to predict recurrence in grade 3 stage I lung adenocarcinoma.
    J Thorac Cardiovasc Surg. 2024;168:648-657.
    >> Share

    August 2024
  65. HOODA Z, Antonoff MB
    Air-Quality variability highlights disparities in lung cancer.
    J Thorac Cardiovasc Surg. 2024 Aug 24:S0022-5223(24)00674.
    >> Share

  66. CHU NQ, Tan KS, Dycoco J, Adusumilli PS, et al
    Determinants of successful minimally invasive surgery (MIS) for resectable non-small cell lung cancer (NSCLC) after neoadjuvant therapy.
    J Thorac Cardiovasc Surg. 2024 Aug 19:S0022-5223(24)00696.
    >> Share


  67. Commentator Discussion: Influence of air quality on lung cancer in people who have never smoked.
    J Thorac Cardiovasc Surg. 2024 Aug 12:S0022-5223(24)00650.
    >> Share

    July 2024

  68. Commentator Discussion: Preoperatively predicting survival outcome for clinical stage IA pure-solid non-small cell lung cancer by radiomics-based machine learning.
    J Thorac Cardiovasc Surg. 2024 Jul 30:S0022-5223(24)00556.
    >> Share

  69. LI T, Zhang Y, Fu F, Chen H, et al
    The Evolution of the Treatment of Non-small Cell Lung Cancer: A Shift in Surgical Paradigm to A More Individualized Approach.
    J Thorac Cardiovasc Surg. 2024 Jul 25:S0022-5223(24)00655.
    >> Share

  70. SMITH R JR, Gee KN, Kalvapudi S, Pachimatla A, et al
    Sex-based Differences in the Lung Immune Microenvironment Are Associated with an Increased Risk of Lung Cancer in Women.
    J Thorac Cardiovasc Surg. 2024 Jul 15:S0022-5223(24)00617.
    >> Share

  71. WATKINS AA, Rizvi TZ, Lopez E, Shehata D, et al
    Trends and Comparative Outcomes Between Operative Approaches for Segmentectomy in Lung Cancer.
    J Thorac Cardiovasc Surg. 2024 Jul 11:S0022-5223(24)00605.
    >> Share

  72. LIN Y
    Accurate predictor of occult mediastinal nodal metastasis in stage I lower-lobe non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2024 Jul 5:S0022-5223(24)00381.
    >> Share

  73. TSUBOKAWA N, Mimae T, Saeki A, Miyata Y, et al
    Feasibility and Comparative Prognosis of Segmentectomy vs. Lobectomy in Centrally Located Small and Solid Dominant cN0 Non-Small Cell Lung Cancer.
    J Thorac Cardiovasc Surg. 2024 Jul 3:S0022-5223(24)00538.
    >> Share

  74. MACBETH F, Williams N, Ahmad I, Treasure T, et al
    Lung surveillance following colorectal cancer pulmonary metastasectomy: Utilization of clinicopathologic risk factors to guide strategy.
    J Thorac Cardiovasc Surg. 2024;168:e10-e11.
    >> Share

  75. ANTONOFF MB, Kui N, Sun R, Deboever N, et al
    Factors associated with receipt of pulmonary metastasectomy in patients with lung-limited metastatic colorectal cancer: Disparities in care and impact on overall survival.
    J Thorac Cardiovasc Surg. 2024;168:263-271.
    >> Share

    June 2024
  76. HUTCHINGS H, Wang A, Grady S, Popoff A, et al
    Influence of Air Quality on Lung Cancer in People Who Have Never Smoked.
    J Thorac Cardiovasc Surg. 2024 Jun 25:S0022-5223(24)00536.
    >> Share

  77. BOTT MJ
    Commentary: Cracking the Code: Deciphering Predictors of Treatment Response in Non-Small Cell Lung Cancer.
    J Thorac Cardiovasc Surg. 2024 Jun 13:S0022-5223(24)00527.
    >> Share


  78. Discussion to: Computational risk model for predicting 2-year malignancy of pulmonary nodules using demographic and radiographic characteristics.
    J Thorac Cardiovasc Surg. 2024;167:1925-1926.
    >> Share

  79. SARNAIK KS, Linden PA, Gasnick A, Bassiri A, et al
    Computational risk model for predicting 2-year malignancy of pulmonary nodules using demographic and radiographic characteristics.
    J Thorac Cardiovasc Surg. 2024;167:1910-1924.
    >> Share

    May 2024
  80. YAN H, Niimi T, Matsunaga T, Fukui M, et al
    Preoperatively Predicting Survival Outcome for Clinical Stage IA Pure-Solid Non-Small Cell Lung Cancer by Radiomics-based Machine Learning.
    J Thorac Cardiovasc Surg. 2024 May 22:S0022-5223(24)00441.
    >> Share

  81. XU L, Si H, Zhuang F, Li C, et al
    Predicting therapeutic response to neoadjuvant immunotherapy based on an integration model in resectable stage IIIA (N2) non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2024 May 17:S0022-5223(24)00437.
    >> Share

  82. HSU DS, Kneuertz PJ
    Commentary: "HIIT"ing the Jackpot with Prehabilitation before Minimally Invasive Lung Cancer Surgery.
    J Thorac Cardiovasc Surg. 2024 May 3:S0022-5223(24)00374.
    >> Share

  83. JONES DR, Bueno R, Harpole DH Jr, Vaporciyan AA, et al
    Thoracic Surgical Oncology Group: An American Association for Thoracic Surgery Clinical Trials Initiative.
    J Thorac Cardiovasc Surg. 2024;167:1584-1588.
    >> Share

    April 2024
  84. ZHOU N, Ripley-Gonzalez JW, Zhang W, Xie K, et al
    Preoperative Exercise Training Decreases Complications of Minimally Invasive Lung Cancer Surgery- A Randomized Controlled Trial.
    J Thorac Cardiovasc Surg. 2024 Apr 11:S0022-5223(24)00296.
    >> Share

  85. ODEH AM, Perez-Tamayo RA, Abdelsattar ZM
    A wedge is still better than stereotactic body radiation therapy in the national cancer database.
    J Thorac Cardiovasc Surg. 2024;167:e100-e101.
    >> Share

  86. KIM AT, Ding L, Lee HB, Ashbrook MJ, et al
    Longer hospitalizations, more complications, and greater readmissions for patients with comorbid psychiatric disorders undergoing pulmonary lobectomy.
    J Thorac Cardiovasc Surg. 2024;167:1502-1511.
    >> Share

    March 2024
  87. RUSCH VW
    Commentary: "Real world" neoadjuvant immunochemotherapy for lung cancer:Additional data but still many questions.
    J Thorac Cardiovasc Surg. 2024 Mar 14:S0022-5223(24)00209.
    >> Share

  88. KRISTENSON K, Hedman K
    Percent predicted peak oxygen uptake is superior to weight-indexed peak oxygen uptake in risk stratification before lung cancer lobectomy.
    J Thorac Cardiovasc Surg. 2024 Mar 5:S0022-5223(24)00187.
    >> Share


  89. Discussion to: AATS 2023: Empiric flap coverage for the pneumonectomy stump: How protective is it? A single-institution cohort study.
    J Thorac Cardiovasc Surg. 2024;167:859-860.
    >> Share


  90. Discussion to: Extent of surgical resection for radiologically subsolid T1N0 invasive lung adenocarcinoma: When is a wedge resection acceptable?
    J Thorac Cardiovasc Surg. 2024;167:810-811.
    >> Share

  91. STEIMER D, Coughlin JM, Yates E, Xie Y, et al
    Empiric flap coverage for the pneumonectomy stump: How protective is it? A single-institution cohort study.
    J Thorac Cardiovasc Surg. 2024;167:849-858.
    >> Share

  92. SACHDEVA UM
    Commentary: The genes stand alone: Genetic risk factors predict early pulmonary recurrence of colorectal carcinoma metastases.
    J Thorac Cardiovasc Surg. 2024;167:820-821.
    >> Share

  93. DEBOEVER N, Bayley EM, Eisenberg MA, Hofstetter WL, et al
    Lung surveillance following colorectal cancer pulmonary metastasectomy: Utilization of clinicopathologic risk factors to guide strategy.
    J Thorac Cardiovasc Surg. 2024;167:814-819.
    >> Share

  94. ZHANG C, Pan Y, Li H, Zhang Y, et al
    Extent of surgical resection for radiologically subsolid T1N0 invasive lung adenocarcinoma: When is a wedge resection acceptable?
    J Thorac Cardiovasc Surg. 2024;167:797-809.
    >> Share

    February 2024
  95. COOPER A, Chaft JE, Bott MJ
    Induction Therapy for Non-Small Cell Lung Cancer.
    J Thorac Cardiovasc Surg. 2024 Feb 12:S0022-5223(24)00160.
    >> Share


  96. Discussion to: Surgical outcomes after chemotherapy plus nivolumab and chemotherapy plus nivolumab and ipilimumab in patients with non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2024 Feb 10:S0022-5223(24)00022.
    >> Share

  97. KOREVAAR DA, Annema JT
    Targeted versus systematic nodal staging in early-stage lung cancer.
    J Thorac Cardiovasc Surg. 2024 Feb 8:S0022-5223(24)00004.
    >> Share

  98. CALL S, Reig-Oussedik N, Obiols C, Sanz-Santos J, et al
    Video-assisted mediastinoscopic lymphadenectomy (VAMLA): mature results for staging non-small cell lung cancer with normal mediastinum.
    J Thorac Cardiovasc Surg. 2024 Feb 2:S0022-5223(24)00098.
    >> Share

  99. ZHANG X, Tsauo J, Tian P, Zhao L, et al
    Randomized comparison of the four-hook anchor device and hook-wire use for the preoperative localization of pulmonary nodules.
    J Thorac Cardiovasc Surg. 2024;167:498-507.
    >> Share

    January 2024

  100. Discussion to: National enrollment of lung cancer clinical trials is disproportionate based on race and health care access.
    J Thorac Cardiovasc Surg. 2024 Jan 27:S0022-5223(23)01209.
    >> Share

  101. MARTIN TK, Dinerman A, Sudhaman S, Budde G, et al
    Early real-world experience monitoring circulating tumor DNA in resected early-stage non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2024 Jan 18:S0022-5223(24)00075.
    >> Share

  102. FUKUI M, Matsunaga T, Hattori A, Takamochi K, et al
    Prognostic significance of preoperative exercise tolerance in patients with early-stage lung cancer.
    J Thorac Cardiovasc Surg. 2024 Jan 11:S0022-5223(24)00006.
    >> Share

  103. LIN N, Berry MF
    Commentary: Re-consult surgery for lung cancer patients? The role of resection after initial non-operative therapy.
    J Thorac Cardiovasc Surg. 2024 Jan 9:S0022-5223(24)00007.
    >> Share

  104. TOHMASI S, Puri V
    Commentary: Segmentectomy versus lobectomy: Are the findings of the JCOG 0802 and CALGB 140503 trials generalizable to the US population?
    J Thorac Cardiovasc Surg. 2024;167:365-366.
    >> Share

  105. POTTER AL, Kim J, McCarthy ML, Senthil P, et al
    Segmentectomy versus lobectomy in the United States: Outcomes after resection for first primary lung cancer and treatment patterns for second primary lung cancers.
    J Thorac Cardiovasc Surg. 2024;167:350-364.
    >> Share

    December 2023

  106. Discussion to: Preoperative predictors of spread through air spaces in lung cancer.
    J Thorac Cardiovasc Surg. 2023 Dec 27:S0022-5223(23)01119.
    >> Share


  107. Discussion to: Lung resection after initial nonoperative treatment for non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2023 Dec 27:S0022-5223(23)01129.
    >> Share

  108. KWAK M, Bassiri A, Jiang B, Sinopoli J, et al
    National enrollment of lung cancer clinical trials is disproportionate based on race and health care access.
    J Thorac Cardiovasc Surg. 2023 Dec 18:S0022-5223(23)01199.
    >> Share

  109. SAKOWITZ S, Bakhtiyar SS, Curry J, Ali K, et al
    Association of Neighborhood Socioeconomic Disadvantage with Utilization of Minimally Invasive Resection for Non-Small Cell Lung Cancer.
    J Thorac Cardiovasc Surg. 2023 Dec 13:S0022-5223(23)01195.
    >> Share

  110. DONINGTON J, Hu X, Zhang S, Song Y, et al
    Event-Free Survival as a Predictor of Overall Survival and Recurrence Burden of Patients with Non-Small Cell Lung Cancer Receiving Neoadjuvant Therapy.
    J Thorac Cardiovasc Surg. 2023 Dec 11:S0022-5223(23)01193.
    >> Share

  111. SERVAIS EL
    Commentary: Utilization and equity in lung cancer screening: time to abandon the one-size-fits-all approach?
    J Thorac Cardiovasc Surg. 2023 Dec 4:S0022-5223(23)01122.
    >> Share


  112. Discussion to: Superior sulcus non-small cell lung cancers (Pancoast tumors): Current outcomes after multidisciplinary management.
    J Thorac Cardiovasc Surg. 2023;166:1488-1489.
    >> Share

  113. MCLAUGHLIN K, Tan KS, Dycoco J, Chen MF, et al
    Superior sulcus non-small cell lung cancers (Pancoast tumors): Current outcomes after multidisciplinary management.
    J Thorac Cardiovasc Surg. 2023;166:1477-1487.
    >> Share

  114. CAO H, Ma Z, Li Y, Zhang Y, et al
    Prognostic value of KRAS G12C mutation in lung adenocarcinoma stratified by stages and radiological features.
    J Thorac Cardiovasc Surg. 2023;166:e479-e499.
    >> Share

  115. SARKARIA IS, Martin LW, Rice DC, Blackmon SH, et al
    Pafolacianine for intraoperative molecular imaging of cancer in the lung: The ELUCIDATE trial.
    J Thorac Cardiovasc Surg. 2023;166:e468-e478.
    >> Share

    November 2023
  116. DUNNE EG, Fick CN, Tan KS, Toumbacaris N, et al
    Lung Resection After Initial Nonoperative Treatment for Non-Small Cell Lung Cancer.
    J Thorac Cardiovasc Surg. 2023 Nov 30:S0022-5223(23)01116.
    >> Share


  117. Discussion to: Induction chemoimmunotherapy with surgery versus concurrent chemoradiation followed by immunotherapy for stage III-N2 non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2023 Nov 28:S0022-5223(23)00992.
    >> Share

  118. TASNIM S, Raja S, Mukhopadhyay S, Blackstone EH, et al
    Preoperative Predictors of Spread Through Air Spaces (STAS) in Lung Cancer.
    J Thorac Cardiovasc Surg. 2023 Nov 23:S0022-5223(23)01106.
    >> Share

  119. MANIWA T, Okami J, Miyoshi T, Wakabayashi M, et al
    Lymph node dissection in small peripheral lung cancer: supplemental analysis of JCOG0802/WJOG4607L.
    J Thorac Cardiovasc Surg. 2023 Nov 22:S0022-5223(23)01099.
    >> Share

  120. DYAS AR, Bronsert MR, Stuart CM, Thomas MB, et al
    Analyzing the Impact of the COVID-19 Pandemic on Initial Oncologic Presentation and Treatment of Non-Small Cell Lung Cancer in the United States.
    J Thorac Cardiovasc Surg. 2023 Nov 17:S0022-5223(23)01098.
    >> Share

  121. SULLIVAN KA, Farrokhyar F, Patel YS, Liberman M, et al
    Preoperative Mediastinal Staging in Early-Stage Lung Cancer: Targeted Nodal Sampling is Not Inferior to Systematic Nodal Sampling.
    J Thorac Cardiovasc Surg. 2023 Nov 17:S0022-5223(23)01096.
    >> Share


  122. Discussion to: Association of socioeconomic factors with the receipt of neoadjuvant therapy for patients with non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2023 Nov 17:S0022-5223(23)00979.
    >> Share


  123. Discussion to AATS 2023: Exposure to Agent Orange is associated with increased recurrence after surgical treatment of stage I non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2023 Nov 9:S0022-5223(23)00904.
    >> Share

  124. AL-THANI S, Nasar A, Villena-Vargas J, Chow O, et al
    Should Sampling of Three N2 Stations be a Quality Metric for Curative Resection of Stage I Lung Cancer?
    J Thorac Cardiovasc Surg. 2023 Nov 3:S0022-5223(23)01015.
    >> Share

  125. SEPESI B, Mehran R, Spicer J, Cascone T, et al
    Neostar Trial and The Current Status of Neoadjuvant Therapy in Non-Small Cell Lung Cancer.
    J Thorac Cardiovasc Surg. 2023 Nov 1:S0022-5223(23)01012.
    >> Share

    October 2023

  126. Discussion to: Quality improvement mechanisms to improve lymph node staging for lung cancer: Trends from a statewide database.
    J Thorac Cardiovasc Surg. 2023 Oct 20:S0022-5223(23)00865.
    >> Share


  127. Discussion to: Overall survival in low-comorbidity patients with stage I non-small cell lung cancer who chose stereotactic body radiotherapy compared to surgery.
    J Thorac Cardiovasc Surg. 2023 Oct 20:S0022-5223(23)00867.
    >> Share

  128. REDDY RM
    Commentary: Neoadjuvant Immunotherapy followed by Lung Cancer Resection: Is the Future Already Here?
    J Thorac Cardiovasc Surg. 2023 Oct 18:S0022-5223(23)00980.
    >> Share

  129. POTTER AL, Senthil P, Srinivasan D, Raman V, et al
    Persistent Racial and Sex-based Disparities in Lung Cancer Screening Eligibility.
    J Thorac Cardiovasc Surg. 2023 Oct 18:S0022-5223(23)00981.
    >> Share

  130. WOLF AS
    Commentary: Nothing is free: Surgeons' and radiation oncologists' biases about treating early stage lung cancer in healthy patients.
    J Thorac Cardiovasc Surg. 2023 Oct 17:S0022-5223(23)00986.
    >> Share

  131. KAMTAM DN, Shrager JB
    We should be considering lung cancer screening for never-smoking Asian-American females.
    J Thorac Cardiovasc Surg. 2023 Oct 14:S0022-5223(23)00976.
    >> Share

  132. FELDMAN H, Sepesi B, Leung CH, Lin H, et al
    Surgical Outcomes After Chemotherapy plus Nivolumab and Chemotherapy plus Nivolumab and Ipilimumab in Patients with Non-Small Cell Lung Cancer.
    J Thorac Cardiovasc Surg. 2023 Oct 8:S0022-5223(23)00900.
    >> Share

  133. YOSHINO I, Moriya Y, Suzuki K, Wakabayashi M, et al
    Long-term outcome of patients with peripheral ground-glass opacity-dominant lung cancer after sublobar resections.
    J Thorac Cardiovasc Surg. 2023;166:1222-1231.
    >> Share

  134. STEIMER D, Ugalde Figueroa P
    Commentary: Sublobar resection for ground-glass opacity: Is less really more?
    J Thorac Cardiovasc Surg. 2023;166:1232-1233.
    >> Share

    September 2023

  135. Discussion to: Perspectives, risk factors, and coping mechanisms in patients with self-reported financial burden following lung cancer surgery.
    J Thorac Cardiovasc Surg. 2023 Sep 30:S0022-5223(23)00783.
    >> Share

  136. ANTONOFF MB, Deboever N, Werner R, Altan M, et al
    Surgery for Oligometastatic Non-Small Cell Lung Cancer.
    J Thorac Cardiovasc Surg. 2023 Sep 29:S0022-5223(23)00874.
    >> Share

  137. ELBAHRAWY MM, Kamel MK, Rodriguez-Quintero JH, Vimolratana M, et al
    Association of Socioeconomic Factors with the Receipt of Neoadjuvant Therapy for Patients with Non-Small Cell Lung Cancer.
    J Thorac Cardiovasc Surg. 2023 Sep 21:S0022-5223(23)00857.
    >> Share

  138. KUMAR A, Srinivasan D, Potter A, Mathey-Andrews C, et al
    Induction Chemoimmunotherapy with Surgery versus Concurrent Chemoradiation followed by Immunotherapy for Stage III-N2 Non-small Cell Lung Cancer.
    J Thorac Cardiovasc Surg. 2023 Sep 16:S0022-5223(23)00853.
    >> Share

  139. POTTER AL, Rosenstein AL, Kandala K, Venkateswaran S, et al
    Shortage of Thoracic Surgeons in the United States: Implications for Treatment and Survival for Stage I Lung Cancer Patients.
    J Thorac Cardiovasc Surg. 2023 Sep 14:S0022-5223(23)00796.
    >> Share

  140. SUBRAMANIAN MP, Eaton DB Jr, Labilles UL, Heiden BT, et al
    Exposure to Agent Orange is Associated with Increased Recurrence after Surgical Treatment of Stage I Non-Small Cell Lung Cancer.
    J Thorac Cardiovasc Surg. 2023 Sep 12:S0022-5223(23)00788.
    >> Share

  141. EISENBERG MA, Deboever N, Mills AC, Egyud MR, et al
    Impact of Travel Distance on Receipt of Indicated Adjuvant Therapy in Resected Non-Small Cell Lung Cancer.
    J Thorac Cardiovasc Surg. 2023 Sep 9:S0022-5223(23)00765.
    >> Share

    August 2023
  142. ALTORKI NK, Chow OS
    Cancer and Leukemia Group B 140503: Is it time to turn the page on Lung Cancer Study Group 821?
    J Thorac Cardiovasc Surg. 2023 Aug 18:S0022-5223(23)00725.
    >> Share

    March 2023
  143. D'AMICO TA
    Japanese Oncology Group 0802: Another giant leap.
    J Thorac Cardiovasc Surg. 2023;165:873-875.
    >> Share

  144. CHEN Z, Bernards N, Gregor A, Vannelli C, et al
    Anatomic evaluation of Pancoast tumors using three-dimensional models for surgical strategy development.
    J Thorac Cardiovasc Surg. 2023;165:842-852.
    >> Share

  145. INRA ML, Wasserman GA, Karp J, Cohen S, et al
    Improvement in postoperative lung function in patients with moderate to severe airway obstruction after robotic-assisted thoracoscopic tracheobronchoplasty.
    J Thorac Cardiovasc Surg. 2023;165:876-885.
    >> Share

  146. ZHOU D, Gao Y, Wang H, Xin H, et al
    Prevalence and anatomical characteristics of subsuperior segment in lung lower lobe.
    J Thorac Cardiovasc Surg. 2023;165:864-872.
    >> Share

  147. PEREZ HOLGUIN RA, Olecki EJ, Wong WG, Stahl KA, et al
    Outcomes after sublobar resection versus lobectomy in non-small cell carcinoma in situ.
    J Thorac Cardiovasc Surg. 2023;165:853-861.
    >> Share

  148. BERTOLACCINI L, Spaggiari L
    Commentary: The sublobar resections and the difference between a conjecture and a theorem.
    J Thorac Cardiovasc Surg. 2023;165:862-863.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016